Low-intensity shockwave therapy has attracted attention as a treatment for erectile dysfunction because it aims to influence penile blood flow rather than simply produce an erection during sexual activity. Some trials report improvement in erectile-function scores, while major reviews and Canadian guidance still describe the certainty of evidence as limited.
The clinic’s Erectile Dysfunction information is a useful starting point because erectile difficulty has several possible causes. Shockwave therapy is most often studied in men with vasculogenic erectile dysfunction, where impaired blood flow is thought to play an important role. It is not a universal treatment for every cause of ED.
What Is Shockwave Therapy for ED?
Low-intensity shockwave therapy, often abbreviated LiSWT or Li-ESWT, delivers acoustic energy to penile tissue from outside the body. It is different from the high-energy shockwaves used to break kidney stones.
The proposed mechanism involves mechanical stimulation of tissue and signalling pathways related to blood-vessel function and repair. Researchers have investigated whether this may improve penile blood flow and erectile function over time.
The clinic uses Alma Duo, a device that delivers low-intensity acoustic energy. Its technology page notes that evidence is still developing and that erectile difficulty may have vascular, hormonal, neurological, medication-related or psychological contributors.
What Does the Evidence Show?
The evidence is mixed rather than absent.
A 2025 Cochrane review examined 21 randomized controlled trials involving 1,357 men. Compared with sham treatment, low-intensity shockwave therapy may have produced a small improvement in erectile-function scores in the short term. The review rated the evidence as low certainty because of study limitations, inconsistency and imprecision. It also noted that the average short-term improvement might not be clinically important to patients.
A 2026 systematic review also found statistically significant improvements in erectile-function scores, but most studies did not reach the threshold generally considered a meaningful change for patients. The authors concluded that it remains unclear whether shockwave therapy provides a clinically meaningful benefit and that no specific protocol can yet be considered superior.
This is why statistical improvement and noticeable improvement are not always the same thing.
Why Do Studies Reach Different Conclusions?
Trials vary in the device, energy level, number of pulses, treatment frequency, number of sessions and areas treated. Participants also differ in ED severity, health conditions and use of other therapies.
A 2025 network meta-analysis found that some treatment parameters were associated with larger changes in erectile-function scores, but this does not establish a universally accepted protocol.
The evidence therefore suggests a possible benefit while leaving important questions about who benefits, by how much and with which protocol.
What Does Canadian Guidance Say?
The Canadian Urological Association takes a cautious position. Its erectile dysfunction guideline conditionally suggests against low-intensity shockwave therapy because the certainty of evidence is low. The supporting review found that the estimated improvement did not clearly reach the established threshold for a clinically important change.
That does not mean research has proven shockwave therapy ineffective. It means the evidence was not strong or consistent enough for the guideline panel to recommend routine use.
Newer reviews continue to find possible benefit, but they also highlight low certainty, variable protocols and uncertain clinical importance.
Who Has Been Studied Most?
Much of the research has focused on men with mild to moderate vasculogenic ED. Erectile dysfunction caused mainly by nerve injury, severe vascular disease, medication effects, hormonal problems or psychological factors may not respond in the same way.
The clinic’s Men’s Sexual-Health Treatment pathway therefore begins with physician-led assessment rather than assuming reduced blood flow is the explanation.
A treatment designed to influence vascular function cannot correct every pathway that affects erections.
Is Shockwave Therapy a Cure?
No. Current evidence does not support describing low-intensity shockwave therapy as a cure for erectile dysfunction.
Even in studies showing improvement, responses vary. Some men may notice a change while others may not. Long-term durability is less certain because fewer trials provide extended follow-up.
It is more accurate to describe shockwave therapy as an emerging option that may improve erectile function in selected men, with uncertainty about the size and persistence of benefit.
What About Risks?
Randomized trials generally report few serious treatment-related adverse events, and the 2025 Cochrane review found little to no difference in reported adverse events between shockwave and sham groups. The review still rated the evidence as low certainty.
The clinic’s Alma Duo information notes that temporary discomfort, redness, tingling or bruising can occur and that some medical factors may make the technology unsuitable.
Low reported complication rates should not be translated into “risk-free.”
Questions Worth Asking
Before treatment, useful questions include:
What is the likely cause of my erectile dysfunction?
Is there evidence that my type of ED responds?
Which device and protocol are being used?
What degree of improvement is realistic?
What established alternatives should I consider?
How will my response be measured?
These questions keep the discussion focused on evidence and individual circumstances rather than the technology alone.
Frequently Asked Questions
Does shockwave therapy replace ED medication?
Not necessarily. Established treatments such as PDE5 inhibitor medications remain important options for many men. The right approach depends on medical assessment and individual health.
Does it work immediately?
Shockwave therapy is studied as a course intended to influence tissue function over time, not as an on-demand method for producing an erection. Improvement, when it occurs, is assessed during follow-up.
Is every acoustic-wave device equivalent?
No. Devices differ in how energy is generated and delivered. Findings from one technology or protocol should not automatically be applied to every device marketed for erectile dysfunction.
Should cardiovascular health be reviewed?
Often, yes. Erectile dysfunction can share risk factors with cardiovascular disease and diabetes. New or persistent symptoms may justify broader health assessment before focusing on one treatment.
Where the Evidence Leaves Us
Shockwave therapy for erectile dysfunction is neither proven useless nor established as a predictable cure. Current research suggests that some men, particularly those with vasculogenic ED, may experience improvement. At the same time, major reviews continue to find low-certainty evidence and uncertainty about how meaningful the average benefit is.
That makes careful selection and expectation-setting important. If erectile dysfunction is persistent, the first step is understanding why it is happening. The clinic’s Contact page can be used to arrange an assessment and discuss whether shockwave therapy, an established ED treatment or another approach fits the clinical picture.